Chronic inflammation in the metabolic syndrome: Emphasis on adipose tissue

Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome

Volumn , Issue , 2009, Pages 65-83

  Monteiro, Rosário ^a  

^a University of Porto   (Portugal)

Author keywords

Adipokines; Adipose tissue dysfunction; Endoplasmic reticulum stress; Hypertrophy; Macrophages

Indexed keywords

EID: 77955363620     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-9701-0_4     Document Type: Chapter

References (112)

1. Aguirre V, Uchida T, Yenush L, Davis R and White MF. The c-Jun. NH (2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser (307). J Biol Chem. 2000;275:9047-54.
2. Alberti KG and Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
3. Anthonsen MW, Ronnstrand L, Wernstedt C, Degerman E and Holm C. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J Biol Chem. 1998;273:215-21.
4. Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S and Arikan S. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest. 2007;30:210-4.
5. Balkau B and Charles MA. Comment on the provisional report on the provisional report from WHO consultation. European group for the study of insulin resistance (EGIR). Diabet Med. 1999;16:442-3.
6. Barker RN, Erwig L, Pearce WP, Devine A and Rees AJ. Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology. 1999;67:302-5.
7. Baud V and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001;11:372-7.
8. Bays HE, Gonzalez-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW and Henry RR. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008;6:343-68.
9. Bellingan GJ, Xu P, Cooksley H, Cauldwell H, Shock A, Bottoms S, Haslett C, Mutsaers SE and Laurent GJ. Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation. J Exp Med. 2002;196:1515-21.
10. Bes-Houtmann S, Roche R, Hoareau L, Gonthier MP, Festy F, Caillens H, Gasque P, Lefebvre D'Hellencourt C and Cesari M. Presence of functional TLR2 and TLR4 on human adipocytes. Histochem Cell Biol. 2007;127:131-7.
11. Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, Luo Z and Ruderman N. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factorkappaB pathway in rat liver. Diabetes. 2005;54:3458-65.
12. Bonizzi G and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25:280-8.
13. Borradaile NM, Buhman KK, Listenberger LL, Magee CJ, Morimoto ET, Ory DS and Schaffer JE. A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death. Mol Biol Cell. 2006a; 17:770-8.
14. Borradaile NM, Han X, Harp JD, Gale SE, Ory DS and Schaffer JE. Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res. 2006b; 47:2726-37.
15. Bouloumie A, Sengenes C, Portolan G, Galitzky J and Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes. 2001;50:2080-6.
16. Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenes C, Galitzky J, Lafontan M, Karpe F, Frayn KN and Bouloumie A. Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation. 2008;117:806-15.
17. Caspar-Bauguil S, Cousin B, Galinier A, Segafredo C, Nibbelink M, Andre M, Casteilla L and Penicaud L. Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett. 2005;579:3487-92.
18. Chang L and Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37-40.
19. Charriere G, Cousin B, Arnaud E, Andre M, Bacou F, Penicaud L and Casteilla L. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem. 2003;278:9850-5.
20. Chen CY, Del Gatto-Konczak F, Wu Z and Karin M. Stabilization of interleukin-2 mRNA by the c-Jun. NH2-terminal kinase pathway. Science. 1998;280:1945-9.
21. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M and George J. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002;35:373-9.
22. Chuyen NV. Toxicity of the AGEs generated from the Maillard reaction: on the relationship of food-AGEs and biological-AGEs. Mol Nutr Food Res. 2006;50:1140-9.
23. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS and Obin MS. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46:2347-55.
24. Cobb WS, Burns JM, Kercher KW, Matthews BD, James Norton H and Todd Heniford B. Normal intraabdominal pressure in healthy adults. J Surg Res. 2005;129:231-5.
25. Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, Cousin JL, Laharrague P, Casteilla L and Penicaud L. A role for preadipocytes as macrophage-like cells. FASEB J. 1999;13:305-12.
26. Cross DA, Alessi DR, Cohen P, Andjelkovich M and Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785-9.
27. De Ferranti S and Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem. 2008;54:945-55.
28. Dean JL, Sully G, Clark AR and Saklatvala J. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal. 2004;16:1113-21.
29. Deng J, Lu PD, Zhang Y, Scheuner D, Kaufman RJ, Sonenberg N, Harding HP and Ron D. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol Cell Biol. 2004;24:10161-8.
30. Eckel RH, Grundy SM and Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-28.
31. Einhorn D, Reaven GM and Cobin RH. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2002;9:236-52.
32. Federovitch CM, Ron D and Hampton RY. The dynamic ER: experimental approaches and current questions. Curr Opin Cell Biol. 2005;17:409-14.
33. Frayn KN, Karpe F, Fielding BA, Macdonald IA and Coppack SW. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord. 2003;27:875-88.
34. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ and Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem. 2002;277:48115-21.
35. Ghosh S and Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002;109 Suppl: S81-96.
36. Gregor MF and Hotamisligil GS. Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res. 2007;48:1905-14.
37. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF and Shulman GI. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 1999;48:1270-4.
38. Hegele RA, Joy TR, Al-Attar SA and Rutt BK. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res. 2007;48:1433-44.
39. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M and Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature. 2002;420:333-6.
40. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Zahringer U and Beutler B. CD36 is a sensor of diacylglycerides. Nature. 2005;433:523-7.
41. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-7.
42. Hotamisligil GS, Shargill NS and Spiegelman BM. Adipose expression of tumor necrosis factoralpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87-91.
43. Hu P, Han Z, Couvillon AD, Kaufman RJ and Exton JH. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression. Mol Cell Biol. 2006;26:3071-84.
44. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE and Shulman GI. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest. 2002;109:1321-6.
45. Huynh ML, Fadok VA and Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest. 2002;109:41-50.
46. Jameson JM, Sharp LL, Witherden DA and Havran WL. Regulation of skin cell homeostasis by gamma delta T cells. Front Biosci. 2004;9:2640-51.
47. Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjogren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM and Lonn M. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J. 2006;20:1540-2.
48. Jiang HY, Wek SA, McGrath BC, Scheuner D, Kaufman RJ, Cavener DR and Wek RC. Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Mol Cell Biol. 2003;23:5651-63.
49. Kaneto H, Nakatani Y, Miyatsuka T, Kawamori D, Matsuoka TA, Matsuhisa M, Kajimoto Y, Ichijo H, Yamasaki Y and Hori M. Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat Med. 2004;10:1128-32.
50. Karaskov E, Scott C, Zhang L, Teodoro T, Ravazzola M and Volchuk A. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology. 2006;147:3398-407.
51. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995;270:16483-6.
52. Kershaw EE and Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548-56.
53. Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M and Eizirik DL. Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factorkappaB and endoplasmic reticulum stress. Endocrinology. 2004;145:5087-96.
54. Kitamura T, Kitamura Y, Kuroda S, Hino Y, Ando M, Kotani K, Konishi H, Matsuzaki H, Kikkawa U, Ogawa W and Kasuga M. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol. 1999;19:6286-96.
55. Kyriakis JM and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81:807-69.
56. Laclaustra M, Corella D and Ordovas JM. Metabolic syndrome pathophysiology: the role of adipose tissue. Nutr Metab Cardiovasc Dis. 2007;17:125-39.
57. Lafontan M. Fat cells: afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol. 2005;45:119-46.
58. Lafontan M and Berlan M. Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci. 2003;24:276-83.
59. Lambert DM, Marceau S and Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg. 2005;15:1225-32.
60. Lawrence T and Gilroy DW. Chronic inflammation: a failure of resolution? Int J Exp Pathol. 2007;88:85-94.
61. Lee JY, Sohn KH, Rhee SH and Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem. 2001;276:16683-9.
62. Li Q and Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002;2:725-34.
63. Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, Hofer S, Plachky J, Grone HJ, Kurschus FC, Schmidt AM, Yan SD, Martin E, Schleicher E, Stern DM, Hammerling GG, Nawroth PP and Arnold B. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004;113:1641-50.
64. Lin L. RAGE on the Toll Road? Cell Mol Immunol. 2006;3:351-8.
65. Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L and Scherer PE. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem. 2000;275:24255-63.
66. Liu G and Rondinone CM. JNK: bridging the insulin signaling and inflammatory pathway. Curr Opin Investig Drugs. 2005;6:979-87.
67. Lopez JM, Bennett MK, Sanchez HB, Rosenfeld JM and Osborne TF. Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid. Proc Natl Acad Sci USA. 1996;93:1049-53.
68. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS and Linton MF. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med. 2001;7:699-705.
69. Martin M, Schifferle RE, Cuesta N, Vogel SN, Katz J and Michalek SM. Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J Immunol. 2003;171:717-25.
70. Mattacks CA, Sadler D and Pond CM. Site-specific differences in fatty acid composition of dendritic cells and associated adipose tissue in popliteal depot, mesentery, and omentum and their modulation by chronic inflammation and dietary lipids. Lymphat Res Biol. 2004;2:107-29.
71. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428-35.
72. Mittra S, Bansal VS and Bhatnagar PK. From a glucocentric to a lipocentric approach towards metabolic syndrome. Drug Discov Today. 2008;13:211-8.
73. Monteiro R, De Castro PM, Calhau C and Azevedo I. Adipocyte size and liability to cell death. Obes Surg. 2006;16:804-6.
74. NECP:ATPIII. Executive summary of the National Cholesterol Education Program (NECP) Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
75. Neels JG and Olefsky JM. Inflamed fat: what starts the fire? J Clin Invest. 2006;116:33-5.
76. O'Shea JJ, Gadina M and Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 2002;109 Suppl: S121-31.
77. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH and Hotamisligil GS. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306:457-61.
78. Parhofer KG and Barrett PH. Thematic review series: patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies. J Lipid Res. 2006;47:1620-30.
79. Park JM, Greten FR, Wong A, Westrick RJ, Arthur JS, Otsu K, Hoffmann A, Montminy M and Karin M. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-kappaB as key regulators. Immunity. 2005;23:319-29.
80. Pirola L, Johnston AM and Van Obberghen E. Modulation of insulin action. Diabetologia. 2004;47:170-84.
81. Poulain-Godefroy O and Froguel P. Preadipocyte response and impairment of differentiation in an inflammatory environment. Biochem Biophys Res Commun. 2007;356:662-7.
82. Previs SF, Withers DJ, Ren JM, White MF and Shulman GI. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem. 2000;275:38990-4.
83. Qatanani M and Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007;21:1443-55.
84. Raetz CR. Biochemistry of endotoxins. Annu Rev Biochem. 1990;59:129-70.
85. Ricci R, Sumara G, Sumara I, Rozenberg I, Kurrer M, Akhmedov A, Hersberger M, Eriksson U, Eberli FR, Becher B, Boren J, Chen M, Cybulsky MI, Moore KJ, Freeman MW, Wagner EF, Matter CM and Luscher TF. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science. 2004;306:1558-61.
86. Romanski SA, Nelson RM and Jensen MD. Meal fatty acid uptake in adipose tissue: gender effects in nonobese humans. Am J Physiol Endocrinol Metab. 2000;279:E455-62.
87. Rudich A, Kanety H and Bashan N. Adipose stress-sensing kinases: linking obesity to malfunction. Trends Endocrinol Metab. 2007;18:291-9.
88. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J and Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 1995;96:1395-403.
89. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol. 2007;25:101-37.
90. Sethi JK and Vidal-Puig AJ. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007;48:1253-62.
91. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H and Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116:3015-25.
92. Shoelson SE, Lee J and Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793-801.
93. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW, 2nd, De Furia J, Jick Z, Greenberg AS and Obin MS. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes. 2007;56:2910-8.
94. Takahashi K, Takeya M and Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med Electron Microsc. 2002;35:179-203.
95. Tanabe Y, Koga M, Saito M, Matsunaga Y and Nakayama K. Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARgamma2. J Cell Sci. 2004;117:3605-14.
96. Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia. 2003;46:733-49.
97. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA and Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 1998;93:241-52.
98. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M and Hotamisligil GS. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci USA. 2006;103:10741-6.
99. Vlassara H, Fuh H, Donnelly T and Cybulsky M. Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med. 1995;1:447-56.
100. Wei Y, Wang D, Topczewski F and Pagliassotti MJ. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab. 2006;291:E275-81.
101. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL and Ferrante AW, Jr. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. 2006;116:115-24.
102. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL and Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-808.
103. Wellen KE and Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-9.
104. Winzen R, Gowrishankar G, Bollig F, Redich N, Resch K and Holtmann H. Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol Cell Biol. 2004;24:4835-47.
105. Wolowczuk I, Verwaerde C, Viltart O, Delanoye A, Delacre M, Pot B and Grangette C. Feeding our immune system: impact on metabolism. Journal. 2008; doi: 10.1155/2008/639803.
106. Wu J and Kaufman RJ. From acute ER stress to physiological roles of the Unfolded Protein Response. Cell Death Differ. 2006;13:374-84.
107. Wu S, Tan M, Hu Y, Wang JL, Scheuner D and Kaufman RJ. Ultraviolet light activates NFkappaB through translational inhibition of IkappaBalpha synthesis. J Biol Chem. 2004;279:34898-902.
108. Wymann MP and Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol. 2008;9:162-76.
109. Xanthis A, Hatzitolios A, Koliakos G and Tatola V. Advanced glycosylation end products and nutrition-a possible relation with diabetic atherosclerosis and how to prevent it. J Food Sci. 2007;72:R125-9.
110. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW and Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002;277:50230-6.
111. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M and Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science. 2001;293:1673-7.
112. Zhao L and Ackerman SL. Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol. 2006;18:444-52.